Furthermore, animal models of disease suggest that ablation of MEKK2 expression blocks hypertension-induced cardiac hypertrophy and breast xenograft tumor metastasis, leading to considerable interest in MEKK2 as a therapeutic target. This evidence concerns the gene MAP3K2 and hypertensive disorder.